Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 7/20 | 0.48 |
| ▸ | MEN1 | O00255 | 6/20 | 0.48 |
| ▸ | MAPT | P10636 | 5/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.48 |
| ▸ | HPGD | P15428 | 1/20 | 0.48 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.43 |
| ▸ | FNTA | P49354 | 1/20 | 0.43 |
| ▸ | FNTB | P49356 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 2/20 | 0.42 |
| ▸ | APAF1 | O14727 | 1/20 | 0.42 |
| ▸ | POLB | P06746 | 1/20 | 0.42 |
| ▸ | RECQL | P46063 | 1/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.42 |
| ▸ | MPO | P05164 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
| ▸ | BLM | P54132 | 1/20 | 0.42 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.42 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ammonia Solution, Strong SCHEMBL560495 | 1.00 | KMT2A (0.48) | KMT2AMEN1MAPTKDM4ESMN1; SMN2 | |
| Ammonia Solution, Strong SCHEMBL4811413 | 1.00 | KMT2A (0.48) | KMT2AMEN1MAPTKDM4ESMN1; SMN2 | |
| Ammonia Solution, Strong SCHEMBL4811403 | 1.00 | KMT2A (0.48) | KMT2AMEN1MAPTKDM4ESMN1; SMN2 | |
| Ammonia Solution, Strong SCHEMBL4811423 | 1.00 | KMT2A (0.48) | KMT2AMEN1MAPTKDM4ESMN1; SMN2 | |
| Ammonia Solution, Strong SCHEMBL560400 | 1.00 | KMT2A (0.48) | KMT2AMEN1MAPTKDM4ESMN1; SMN2 | |
| Ammonia Solution, Strong SCHEMBL560398 | 1.00 | KMT2A (0.48) | KMT2AMEN1MAPTKDM4ESMN1; SMN2 | |
| Ammonia Solution, Strong SCHEMBL560399 | 1.00 | KMT2A (0.48) | KMT2AMEN1MAPTKDM4ESMN1; SMN2 | |
| SCHEMBL13844616 | 0.99 | KMT2A (0.49) | KMT2AMEN1MAPTKDM4ESMN1; SMN2 | |
| SCHEMBL560222 | 0.99 | KMT2A (0.49) | KMT2AMEN1MAPTKDM4ESMN1; SMN2 | |
| SCHEMBL559736 | 0.99 | KMT2A (0.49) | KMT2AMEN1MAPTKDM4ESMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7816541-B2 | Process for producing an optically active compound | AJINOMOTO CO., INC. (JP) | 2010-10-19 | — | — | US | disclosed |
| US-20080207920-A1 | PROCESS FOR PRODUCING AN OPTICALLY ACTIVE COMPOUND | AJINOMOTO CO., INC. (JP) | 2008-08-28 | — | — | US | disclosed |
| EP-1956003-A2 | Process for producing an optically active compound | Ajinomoto Co., Inc. (JP) | 2008-08-13 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080207920-A1 | PROCESS FOR PRODUCING AN OPTICALLY ACTIVE COMPOUND | AADAT, ALDOA, ALAD | KMT2A 2106/4885MEN1 1204/4885MAPT 622/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.